CUSIP 21833P301COM NEWCRBPQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
100 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Cormorant Asset Management, LP | 2.34M | $19.09M | −30.0K | Reduced |
| 2 | Orbimed Advisors LLC | 1.60M | $13.00M | +425.0K | Added |
| 3 | Aberdeen Group PLC | 1.32M | $10.76M | +1.13M | Added |
| 4 | Octagon Capital Advisors LP | 955.0K | $7.77M |
| −160.0K |
| Reduced |
| 5 | Vanguard Group Inc | 859.4K | $7.00M | +247.4K | Added |
| 6 | Citadel Advisors LLC | 843.2K | $6.86M | +843.2K | New |
| 7 | Prosight Management, LP | 683.9K | $5.57M | +340.5K | Added |
| 8 | Armistice Capital, LLC | 536.0K | $4.36M | +344.0K | Added |
| 9 | Stonepine Capital Management, LLC | 389.9K | $3.17M | +389.9K | New |
| 10 | Renaissance Technologies LLC | 354.3K | $2.88M | +247.1K | Added |
See every fund holding Corbus Pharmaceuticals Hldgs, with full quarter-over-quarter share changes.
Unlock all holders